EFFEKTIVNOST' PRIMENENIYa LACTOBACILLUS REUTERI U DETEY S MLADENChESKIMI KOLIKAMI


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

One of the most frequent reasons for the visiting a pediatrician by parents with children in the first months of life is intestinal colic (IC). The article discusses the problem of the pathogenesis, diagnosis, and treatment of IC. The use of Lactobacillus reuteri DSM strain in 17938 children with IC reduces their manifestation. It is possible that this effect is associated with changes in the intestinal microbiota. These data make an important contribution to the understanding of the role of violations of bacterial microflora in the pathogenesis of infantile colic and enable their overcoming with the use of probiotics.

全文:

受限制的访问

作者简介

I. Zakharova

E. Kasatkina

参考

  1. Wessel M.A, et al. Paroxismal fussing in infancy, sometimes called “colic". Pediatrics 1954;14:421-35.
  2. Savino F, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 2007;119(1):e124-30.
  3. Lothe L. Studies on infantile colic. Thesis; University of Lund, Malmo, 1989.
  4. Самсыгина Г.А. Алгоритм лечения детских кишечных колик // Consilium medicum. Педиатрия 2009. № 3. С. 55-67.
  5. Paradise J.L. Maternal and other factors in the etiology of infantile colic. JAMA 1996;197: 123-31.
  6. Douwes A.C, Oosterkamp R.F, Fernandes J, et al. Sugar malabsorption in healthy neonates estimated by breath hydrogen. Arch Dis Child 1980;55:512-15.
  7. Lucas A, St James-Roberts I. Crying, fussing and colic behaviour in breast- and bottle-fed infants. 1998;53(1):9-18. PMID: 10193923.
  8. Захарова И.Н., Сугян Н.Г., Андрюхина Е.Н., Дмитриева. Ю.А. Тактика педиатра при младенческих кишечных коликах // РМЖ 2010. Т.18. № 1. С. 11-5.
  9. Savino F, Bailo E, Oggero R, et al. Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr Allergy Immunol 2005;16(1):72-5.
  10. Сугян Н.Г. Клиническое значение короткоцепочечных жирных кислот при функциональных нарушениях желудочно кишечного тракта у детей раннего возраста. Дисс. канд. мед. наук. М., 2010.с.
  11. Lust K.D, Brown J.E, Thomas W. Maternal intake of cruciferous vegetables and other foods and colic symptoms in exclusively breast-fed infants. J Am Diet Assoc 1996;96:46-9.
  12. Запруднов А.М., Мазанкова Л.Н. Микробная флора кишечника и пробиотики//Педиатрия. Прил. 1999. 48 с.
  13. Scheiwiller J, Arrigoni E, Brouns F. Human fecal microbiota develops the ability to degrade type 3 resistant starch during weaning. J Ped Gastroenterol Nutr 2006;43;584-91.
  14. Perman J.A, Montes R.G. Approach to the patient with gas and bloating. In: Gastroenterology. Ed. T. Yamada. JB Lippincott Company, Pholadelphia, 1995:772-82.
  15. Savino F, Cordisco L, Tarasco V, et al. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr 2009;98(10):1582-88.
  16. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 2010;126(3):e526-33. PMID: 20713478.
  17. Mitsuoka T. The human gastrointestinal tract. In: Wood B.J.B, ed. The lactic acid bacteria. v. 1. The lactic acid bacteria in health and disease. New York: Elsevier Applied Science 1992:69-114.
  18. Orla-Jensen S. The lactic acid Bacteria. Det Kongelige Danske Videnskasbernes Selskab. Naturvidenskabelige mathematiske Afdeling, 1919. NS 8.5.2.
  19. Kandler O, Stetter K, Kohl R. Lactobacillus reuteri sp. nov. a new species of heterofermentative lactobacilli. Zbl Bakt Hyg Abt Orig 1980;C1: 264-69.
  20. Sinkiewiczg G, et al. Occurrence of Lactobacillus reuteri in human breast milk. Microbial ecology in health and disease 2008;20:122-26.
  21. Szajewska H, Gyrczuk E, Horvath A.J. Lactobacillus reuteri DSM 17938 for the Management of Infantile Colic in Breastfed Infants: A Randomized, Double-Blind, Placebo-Controlled Trial. Pediatr 2012;pii: S0022-3476( 12)00920-1. doi: 10.1016/j. jpeds.2012.08.004.
  22. Ma X, Mao Y.K, Wang B, et al. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol 2009;296(4):868-75.
  23. Savino F, Tarasco V. New treatmens for infant colic. Current Opinion Pediat 2010;22(6): 791-97.
  24. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 2004;72(9):5308-14.
  25. Talarico T.L, Casas I.A, Chung T.C, Dobrogosz W.J. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother 1988;32( 12): 1854-8. Entrez PubMed 3245697.
  26. Zhao Q, Maddox I.S, Mutukumira A, et al. The effect of cell immobilization on the antibacterial activity of Lactobacillus reuteri DPC16 cells during passage through a simulated gastrointestinal tract system. World J Microbiol Biotechnol 2012;28(10):3025-37. doi: 10.1007/ s11274-012-1113-3.
  27. Talarico T.L, Dobrogosz W.J. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother 1989;33(5):674-9. Entrez PubMed 2751282.
  28. Shornikova A.V, Casas I.A, Mykkanen H, Salo E, Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997;16:1103-7.
  29. Francavilla R, Lionetti E, Castellaneta S, et al. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhea a double-blind study. Entrez PubMed 9427453; Aliment Pharmacol Ther 2012;36(4):363-69.
  30. Saggioro A, Caroli M, Pasini M, et al. Helicobacter pylori eradication with Lactobacillus reuteri. A double blind placebo-controlled study. Dig Liver Dis 2005;37(1):S88, abstr. PO1.49.
  31. Efrati C, Nicolini G, Cannaviello C, et al. Helicobacter pylori eradication: Sequential therapy and Lactobacillus reuteri supplementation. World J Gastroenterol 2012;18(43):6250-450.
  32. Siemensma A.D, Wicher J.W, Bar H.J. The importance of peptide length in hypoallergenic infant formulae. Trends Food Scien Technol 1993;4:16-21.
  33. Lucassen P.L, et al. Effectiveness of treatments for infantile colic: systematic review. BMJ 1998;316(7144):1563-69.
  34. Savino F, et al. Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol 2011;30;11:157.
  35. Hunter C, Dimaguila M.A, Gal P, et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight № 1000 grams: a sequential analysis. BMC Pediatr 2012;12:142. doi: 10.1186/1471-243112-142.
  36. Чайка В.К., Говоруха И.Т., Батман Ю.А, О.М. Бабенко. Опыт использования препарата Биогая у беременных // Перинатология и педиатрия 2010. № 1. С. 23-7.
  37. Abrahamsson T, Jakobsson T, Sinkiewicz G, et al. Intestinal microbiota in infants supplemented with the probiotic bacterium Lactobacillus reuteri. J Ped Gastroenterol Nutr 40(5):692, abstract PN 1-17.
  38. Bruyas-Bertholon V, Lachaux A, Dubois J.P, et al. Which treatments for infantile colics? Presse Med 2012;41(7-8):e404-10.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2013
##common.cookie##